Natco Pharma net dips 68% in Q2
Hyderabad: Hyderabad-based Natco Pharma reported a dip in its net profit for the quarter ended September 30, 2021 to Rs 65.1 crore as against Rs 203.90 crore in the same period last fiscal. The company registered a Rs 415.2 crore consolidated revenue during the quarter under review as against Rs 827.9 crore in the second […]
Updated On - 11 November 2021, 06:17 PM
Hyderabad: Hyderabad-based Natco Pharma reported a dip in its net profit for the quarter ended September 30, 2021 to Rs 65.1 crore as against Rs 203.90 crore in the same period last fiscal.
The company registered a Rs 415.2 crore consolidated revenue during the quarter under review as against Rs 827.9 crore in the second quarter of 2020-21.
The decline in revenue and profits compared to last year’s quarter is primarily due to a one-off contribution in prior period earnings. The company is poised for growth during the latter half of this financial year and confident of a strong rebound in business, Natco said.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .